Effect of External Oblique Intercostal Block Versus Paravertebral Block on Postoperative Pain and Complications in Open Nephrectomy Patients
Launched by HACETTEPE UNIVERSITY · Jul 8, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of pain relief used during surgery for kidney removal (called open nephrectomy). The researchers want to find out which method—either the external oblique intercostal block or the paravertebral block—works better to reduce pain and lower the chance of complications after surgery.
People who might join this study are adults aged 18 to 90 who have a specific type of kidney cancer (stage 2 renal cell carcinoma) and are scheduled for open kidney removal surgery without lymph node removal. Participants need to be in generally good health, able to understand and agree to the study, and have no serious nerve problems, liver failure, blood clotting issues, or allergies to local anesthetics (numbing medicines). If you join, you can expect to receive one of the two pain-relief treatments during surgery, and the medical team will monitor your pain levels and any side effects afterward to see which method helps you recover better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 to 90 years
- • Stage 2 renal cell carcinoma scheduled for open radical nephrectomy without lymph node dissection
- • ASA classification I-III
- • Mini-Mental State Examination score ≥24
- • Provided written informed consent
- Exclusion Criteria:
- • Neuropathy
- • Hepatic failure
- • Coagulopathy
- • Local anesthetic allergy
- • Mini-Mental State Examination score \<24
- • Refusal to participate
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported